Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(100.0%)

6Total

N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06256380Not ApplicableRecruiting

Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder

Role: collaborator

NCT07189559Not ApplicableCompleted

School-Based Body Image Concerns Prevention

Role: lead

NCT07158593Not ApplicableCompleted

School-Based Eating Disorder Prevention

Role: lead

NCT04046926Completed

Relapse in Anorexia Nervosa. A Cohort Study

Role: lead

NCT05290285Not ApplicableRecruiting

Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo

Role: lead

NCT01611220Not ApplicableCompleted

Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa

Role: lead

NCT02021890Not ApplicableCompleted

Efficacy Study of Standard Ballroom and Latin Dance Program in Type 2 Diabetes and Obesity

Role: collaborator

All 7 trials loaded